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Intrinsic Inputs Governs even-skipped Enhancer
ctivity in a Subset of Pericardial and Dorsal
uscle Progenitors
Stefan Knirr and Manfred Frasch1
Department of Biochemistry and Molecular Biology, Box 1020, Mount Sinai
School of Medicine, New York, New York 10029
Individual somatic muscles and heart progenitors are specified at defined positions within the mesodermal layer of
Drosophila. The expression of the homeobox gene even-skipped (eve) identifies one specific subset of cells in the dorsal
esoderm, which give rise to particular pericardial cells and dorsal body wall muscles. Genetic analysis has shown that the
nduction of eve in these cells involves the combined activities of genes encoding mesoderm-intrinsic factors, such as
inman (Tin), and spatially restricted signaling activities that are largely derived from the ectoderm, particularly those
ncoded by wingless (wg) and decapentaplegic (dpp). Here we show that a Dpp-activated Smad protein, phosphorylated
ad, is colocalized in eve-expressing cells during an extended developmental period. We demonstrate further that a
esodermally active enhancer of eve contains several Smad and Tin binding sites that are essential for enhancer activity
in vivo. This enhancer also contains a number of binding sites for the Wg-effector Pangolin (Pan/Lef-1), which are required
for full levels of enhancer activity. However, we find that their main function is to prevent ectopic enhancer activity in the
dorsal mesoderm. This suggests that, in the absence of Wg signaling, Pan binding serves to abrogate the synergistic activities
of Smads and Tin in eve activation while, in cells that receive Wg signals, Pan is converted into a coactivator that promotes
eve induction. Together, these data show that the eve enhancer integrates several regulatory pathways via the combinatorial
inding of the mesoderm-intrinsic regulator Tin and the effectors of the Dpp and Wg signals. © 2001 Academic Press
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An early and major subdivision of the embryonic meso-
derm of Drosophila occurs along the dorsoventral dimen-
ion. As a result, the cells in the dorsal portion of the
esoderm are fated to develop into various cardiac cell
ypes, several different dorsal somatic muscle fibers, and
isceral mesodermal cells that give rise to circular midgut
uscles. Specification of all of these dorsal mesodermal
erivatives depends on inductive Dpp signals released by
he dorsal ectoderm, as well as the mesoderm-autonomous
unction of the homeobox gene tinman (Azpiazu and
rasch, 1993; Bodmer, 1993; Staehling-Hampton et al.,
1 To whom correspondence should be addressed at Mount Sinai
School of Medicine, Department of Biochemistry and Molecular
Biology, One Gustave L. Levy Place, Box 1020, New York, NY
10029. Fax: (212) 860-9279. E-mail: manfred.frasch@mssm.edu.
0012-1606/01 $35.00
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All rights of reproduction in any form reserved.994; Frasch, 1995; Yin and Frasch, 1998). Additional im-
ortant cues, which are provided by Wingless (Wg) signals
nd are differentially active along the anteroposterior di-
ension, control the distinction between heart and somatic
uscle progenitors versus visceral mesoderm progenitors
Park et al., 1996; Wu et al., 1995; Azpiazu et al., 1996).
hus it has been proposed that both cardiogenic and so-
atic muscle cell fates are induced in areas of the meso-
erm where dorsally restricted Dpp and transversely striped
g signaling intersect (Bodmer and Frasch, 1999; Carmena
t al., 1998; Frasch, 1999; Frasch and Nguyen, 1999). In the
esoderm, these areas are marked by the combinatorial
xpression of the Dpp target tinman (tin) and the Wg target
loppy paired (slp), which encodes a forkhead domain
ranscription factor, and both tin and slp are critical for
promoting heart and somatic muscle fates (Riechmann et
al., 1997; Xu et al., 1998; Lee and Frasch, 2000). By contrast,
visceral muscle fates are induced in the intervening areas
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14 Knirr and Fraschthat receive Dpp, but no Wg signals, and their determina-
tion requires the presence of tin but the absence of slp
ctivity.
There are at least two different models that could explain
he combined roles of these signaling and transcriptional
vents in mesodermal cell fate specification. In a strictly
equential model, regulatory events would occur in a linear
rder, in which each regulator is required only during a
ingle step of a regulatory hierarchy. For example, Dpp and
g could be simply required to induce the expression of tin
nd slp during an early event of mesoderm patterning. In
ubsequent steps, tin and slp could promote the activation
f prepatterning gene(s) that define cardio- and myogenic
reas, without a renewed requirement for Dpp and Wg
ignals. This type of prepatterning gene(s) could in turn
ctivate heart and muscle specification genes, perhaps to-
ether with newly active signals but without requiring any
f the previously active regulators. By contrast, in an
ntegrative (or combinatorial) model, the same signals and
ranscriptional regulators would be active repeatedly during
ultiple steps in a cascade and their particular combination
n any given cell would provide a readout for the activation
f specific regulatory genes. For example, a combination of
pp and Wg signaling as well as the function of Tin, Slp,
nd additional regulators could be required simultaneously
o activate transcription of a particular heart or muscle
pecification gene. Available genetic data appear to argue
gainst a strictly sequential model for mesoderm develop-
ent and provide some support for an integrative model or
combination of the two. Ultimately, functional analysis
f enhancers and the identification of essential binding
actors will be required to define the sets of inputs that are
ecessary to control different muscle and heart specifica-
ion genes.
One of the best-studied regulatory genes that are acti-
ated in specific heart and somatic muscle progenitors is
he homeobox gene even-skipped (eve). During stage 10 of
mbryogenesis, eve becomes expressed in small clusters of
ells in the dorsal mesoderm, each of which includes the
rogenitors of two pericardial cells and two or three dorsal
omatic muscles (Frasch et al., 1987). It has been shown
hat eve activity is required for proper differentiation of
hese particular pericardial cells, although its requirement
n dorsal somatic muscle differentiation has not been estab-
ished (Su et al., 1999). eve expression depends on dpp, wg,
in, and slp and, during its onset of expression, it is
oexpressed with Tin, Slp, as well as the bHLH protein
ethal of scute (L’sc) in mesodermal cells (Azpiazu and
rasch, 1993; Bodmer, 1993; Frasch, 1995; Wu et al., 1995;
iechmann et al., 1997; Carmena et al., 1998; Yin and
rasch, 1998; Lee and Frasch, 2000). In addition, the eve
ells are transiently positive for activated MAPK, which
eflects the additional requirement for receptor tyrosine
inase signaling in eve activation (Buff et al., 1998; Car-
ena et al., 1998; Michelson et al., 1998; Halfon et al.,
000). During its later phase of expression, maintenance of
ve expression in the pericardial cells and in the developing
s
S
Copyright © 2001 by Academic Press. All rightorsal somatic muscle 1 (also known as DA1), requires the
ctivity of the zinc-finger and homeodomain encoding gene
fh-1 and the activity of the Zn-finger encoding gene
ru¨ppel (Kr), respectively (Su et al., 1999; Ruiz-Gomez et
l., 1997).
Here we present a molecular analysis of regulatory inputs
hat are received by the eve promoter in the mesoderm.
sing antibodies that recognize activated Mad, we demon-
trate that the Dpp pathway is active during an extended
eriod in the mesodermal eve cells, which suggests that eve
eceives direct Dpp inputs and that Dpp can act during
uccessive steps in the regulatory cascade of heart and
uscle development. Functional dissection of an eve en-
ancer, which is active specifically in mesodermal eve
rogenitors and their descendants, demonstrates that eve
eceives direct inputs from multiple regulators. In addition
o Smads, which mediate Dpp inputs, these include the
ef1 homolog Pangolin (Pan), which appears to be converted
rom a repressor to an activator by Wg signals, and Tinman.
owever, Slp does not appear to interact with this eve
nhancer, suggesting that its action is restricted to a step
urther upstream in the regulatory hierarchy. Together,
hese data show that multiple, although not all of the
nown upstream regulatory activities of eve converge on its
esodermal enhancer and provide support for the occur-
ence of both sequential and integrative regulation mecha-
isms in mesodermal tissue development.
MATERIALS AND METHODS
Histochemistry
Immunological stainings of whole-mount embryos, using the
VectaStain ABC elite kit (Vector Laboratories) were done as
described in Azpiazu et al. (1996) and in situ hybridization/
ntibody double stainings as described in Knirr et al. (1999). The
rabbit-anti Phospho-Smad1 antiserum (PS1) was a gift from
C.-H. Heldin and was used with the VectaStain ABC elite kit in
combination with the Renaissance TSA direct kit (NEN) (1:2000;
for whole mounts) and TSA indirect kits (1:5000; for sectioning),
respectively. Rabbit-anti bGal antibodies (1:2000) were from
Cappel (ICN). Confocal laser scanning was performed with a
Leica TCS-SP microscope in the sequential scanning mode for
the two colors.
Molecular Techniques
An approximately 100-bp RsaI/PstI fragment from the 39 end
of the eve cDNA pS72-6 (Frasch et al., 1987) was used to initiate
a genomic walk using an EMBL3 phage library obtained from
M. Noll. Overlapping restriction fragments were tested for their
in vivo activity using the reporter transformation vector
pCaSpeRhs43 bGal (Thummel and Pirrotta, 1992) in the back-
round of yw embryos. An initial BamHI/SalI fragment (14.6 kb
o 18.4 kb, with 11 bp corresponding to the transcriptional start
ite of eve (Frasch et al., 1987), was further subdivided. A 900-bp
phI/StuI fragment (15.7 to 16.6 kb), termed EME 0.9SS was
s of reproduction in any form reserved.
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15Integrative Inputs Controlling Mesodermal eve Enhancergenerated, which drove reporter gene expression at stage 10 (lacZ
RNA) or stage 11 (bGal protein) exclusively in dorsal
mesodermal cell clusters. Following sequencing, smaller sub-
fragments of EME 0.9SS (see below at Fig. 3) were generated by
PCR, cloned into pBluescript KS 1 , and recloned into
CaSpeRhs43 bGal.
DNase I protection assays were done using bacterially ex-
pressed GST fusion proteins (Pan, Medea, Tin) as described in
Yin et al. (1997), Xu et al. (1998), and Lee and Frasch (2000). A
GST-zfh-1 homeodomain fusion construct was obtained from
J. Treisman. Binding sites for Medea, Tinman, Zfh-1, Pangolin,
and a forkhead domain consensus binding site were mutated by
introducing restriction sites (see below at Fig. 3, underlines, and
Fig. 6) using the linker scanning protocol as described in Lee and
Frasch (2000). Once confirmed by sequencing, the mutated frag-
ments were recloned into pCaSpeRhs43 bGal vector for in vivo
analysis.
RESULTS AND DISCUSSION
Mesodermal eve Progenitors Contain Nuclear
Phospho-Mad
Dpp signaling is strictly required for the expression of eve
in the dorsal mesoderm (Frasch, 1995). To determine
whether the effects of Dpp on eve are potentially direct and
to examine the dynamics and spatial distribution of meso-
dermal Dpp signaling activity, we stained embryos with
anti-phospho-Smad1 antibodies, which specifically recog-
nize activated Mad protein (Persson et al., 1998; Teleman
and Cohen, 2000; Rushlow et al., 2001). As shown in Fig.
1A, until embryonic stage 8 phosphorylated Mad (P-Mad) is
detected only in the nuclei of the dorsal ectoderm and in
decreasing amounts in the amnioserosa, but not in the
mesoderm. Mesodermal P-Mad is first detected during stage
9 (data not shown), and during stage 10 all nuclei of the
dorsal mesoderm contain high levels of P-Mad (Fig. 1B). The
dorsoventral extent of the P-Mad domain correlates with
the extent of the tinman and bagpipe expression domains,
which are induced by Dpp during this stage (Staehling-
Hampton et al., 1994; Frasch, 1995). At late stage 12, P-Mad
is detected only in the dorsal-most cells of the ectoderm
and, more weakly, of the mesoderm as well as in the
bordering cells of the amnioserosa (Fig. 1C). This pattern
correlates with the narrowed expression of dpp along the
dorsal margin of the ectoderm during this stage (St.
Johnston and Gelbart, 1987). In addition, dpp expression in
parasegment 7 of the visceral mesoderm generates P-Mad
signals within these particular cells as well as in the
adjacent cells of the endoderm and the somatic mesoderm
(Fig. 1C).
To examine whether the Dpp signaling pathway contin-
ues to be active in eve-expressing mesodermal progenitors
we stained embryos for both P-Mad and Eve proteins.
Confocal laser scanning was used to separate the fluores-
cent signals from ectodermal versus mesodermal cell layers
(Figs. 1D–1I). This analysis showed that between stage 10
Copyright © 2001 by Academic Press. All rightand early stage 12, all Eve-expressing mesodermal cells
contain nuclear P-Mad (Figs. 1D and 1E). However, during
late stage 12, there is a strong decrease of P-Mad levels in
the eve cells and by the end of stage 12 the majority of eve
cells no longer contain detectable levels of P-Mad. Based on
stainings of stage 14 embryos (Fig. 1I), it appears that the
cells that maintain low levels of P-Mad for a longer period
correspond to the eve pericardial progenitors, whereas the
eve muscle progenitors lose P-Mad during late stage 12.
Interestingly, some yet unidentified cells located between
the Eve clusters in the cardiogenic mesoderm continue to
stain strongly for P-Mad until stage 14 (Figs. 1G and 1I,
arrow), but thereafter P-Mad is no longer detectable in the
dorsal mesoderm (data not shown). Together, these obser-
vations show that the Dpp signaling pathway is active for
an extended period in the mesodermal eve progenitors, thus
invoking the possibility that activated Smad proteins have
direct roles in eve induction, perhaps by binding to specific
enhancer sequences of eve. In addition, the differential
maintenance of intracellular Dpp signaling, as measured by
the levels of P-Mad, in different dorsal mesodermal cells
could contribute to the diversification of their developmen-
tal fates. Because, even at late stages, the Dpp distribution
along the A/P axis is rather uniform in the dorsal ectoderm
(which is also evident from the uniform ectodermal P-Mad
distribution; Fig. 1H), its signaling pathway must be modu-
lated further downstream. For example, Dpp signaling
could be downregulated in specific mesodermal cells at the
level of the expression of the receptor or an antagonist such
as Dad (Tsuneizumi et al., 1997).
Discrete eve Enhancer Fragments Drive Expression
in Mesodermal eve Progenitors
Functional dissection of eve flanking regions identified a
900-bp fragment, located about 5.7–6.6 kb downstream of
the eve transcription start site and named Eve Mesodermal
nhancer (EME) 0.9SS (see Fig. 3, below), which is able to
eproduce the full mesodermal pattern of endogenous eve
xpression between embryonic early stage 11 and stage 15.
etween stages 11 and 12, reporter gene expression occurs
xclusively in the 11 (plus one posterior) bilateral clusters
f mesodermal eve progenitors (Fig. 2A; see also Fujioka et
l., 1999; Su et al., 1999; Halfon et al., 2000). Perduring
bGalactosidase (bGal) protein at stage 16 shows that these
clusters include the progenitors of the eve pericardial cells
nd muscle 1 (DA1) (Fig. 2B1). Because the long half life of
bGal protein precludes accurate determination of the tem-
poral dynamics of reporter gene expression, we stained
transgenic embryos for both lacZ mRNA, which is less
stable, and Eve. This analysis confirmed that the EME 0.9SS
enhancer is active in all pericardial cells and muscle 1
precursors until stage 15 (Fig. 2B2) and continues to be
active in the eve pericardial cells, predominantly those
s of reproduction in any form reserved.
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16 Knirr and FraschFIG. 1. Phospho-Mad distribution and Eve expression during embryogenesis after gastrulation. (A–C) Cross-sectioned embryos stained with
nti-P-Smad1 antibodies. (A) Stage 8 embryos with P-Mad signals in the dorsal ectoderm and some neighboring amnioserosa cells (as). The border
etween ectoderm (ec) and mesoderm (ms) is indicated by a solid line. (B) Stage 10 embryo with P-Mad signals in the dorsal ectoderm (ec), dorsal
esoderm (ms), and amnioserosa (as). (C) Late stage 12 embryo sectioned through parasegment 7 with P-Mad signals in the dorsalmost cells of
he ectoderm (ec), adjacent amnioserosa cells, cardiogenic mesoderm (cm), visceral mesoderm (vm), somatic mesoderm (sm), and endoderm (en).
n addition, there is a ventral domain of ectodermal and mesodermal P-Mad. (D–I) Confocal images with P-Mad in red and Eve in green. Enlarged
ell clusters indicated by arrowheads are shown in insets both as overlays and separate channels. (D) Merged scans of the mesodermal layer of
tage 10 embryo (comparable to the stage shown in B) showing that the nuclei of all Eve cells contain P-Mad. (E) Merged mesodermal scans of
arly stage 12 embryo showing a narrowed band of P-Mad staining. While all Eve nuclei contain P-Mad, the levels of P-Mad are more variable
ompared to those of stage 10. (F) Merged ectodermal scans from same embryo as in E showing narrow bands of dorsal and ventrolateral
ctodermal cells with nuclear P-Mad. (G) Merged mesodermal scans of late stage 12 embryo showing that only some of the Eve nuclei retain (low)
evels of P-Mad. Arrow indicates mesodermal nucleus with strong P-Mad signals. (H) Merged ectodermal scans from same embryo as in G
howing P-Mad in dorsal and ventrolateral ectodermal cells. (I) Merged mesodermal scans of stage 14 embryo showing weak P-Mad signals in the
ericardial cells (which are recognized by their dorsal position and oval shape at this stage; white arrowhead) and absence of P-Mad in adjacent
uscle precursors (green arrowheads). Arrow indicates mesodermal nucleus with strong P-Mad signals. (Note that because of the curvature of thembryo the bottom part of E, G, and I includes lateral ectodermal signals.)
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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17Integrative Inputs Controlling Mesodermal eve Enhancersurrounding the posterior portion of the dorsal vessel (the
heart proper), until the end of embryogenesis (data not
shown). This pattern is similar to that of eve mRNA, except
that eve continues to be expressed evenly in pericardial
FIG. 2. Activity of eve enhancer fragments in vivo. (A), (C), (E),
reporter genes as indicated and were stained with bGal antibodies.
stained for lacZ mRNA (green) and Eve protein (red). Each of thes
etected in pericardial and/or muscle precursors. (B1) shows a late s
c: pericardial progenitors and cells; M1: muscle 1 progenitors andcells along the entire length of the dorsal vessel (Frasch et F
Copyright © 2001 by Academic Press. All rightl., 1987). A second difference is ectopic reporter gene
xpression, which is observed following stage 15 in muscle
, several ventral muscles, and in ectodermal muscle at-
achment sites (Figs. 2B1 and 2B2; and data not shown).
G) show stage 11/early stage 12 embryos, which carried eve-lacZ
(D), (F), and (H) show corresponding embryos from the same lines
els shows the latest stage for which significant lacZ RNA can be
16 embryo carrying EME B0.9SS-lacZ and stained for bGal protein.
cytia; M2: muscle 2.and (
(B2),
e pan
tagerom this we infer that EME 0.9SS lacks site(s) for negative
s of reproduction in any form reserved.
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18 Knirr and Fraschregulators, which normally prevent eve activation by late-
cting regulators outside of its normal domain of expres-
ion.
The spatial and temporal activity of a subfragment com-
rising 709 bp of the 59 portion of EME 0.9SS, EME A (Fig.
) is identical to the full-length fragment (data not shown).
oth the 394-bp fragment EME B, from the center of EME
.9SS, and the longer EME C have activities similar to that
f EME 0.9SS, although their lacZ expression already ter-
minates at stage 14 in muscle 1 precursors and there is little
ectopic expression (Figs. 2C and 2D).
To define minimally active enhancer fragments, EME B
was further subdivided into two overlapping portions, EME
B59 (232 bp) and EME B39 (361 bp) (Fig. 3). Both subfrag-
ments drive expression in mesodermal eve progenitors,
lthough the levels of EME B59 activity are lower than those
f the parental EME B fragment (Figs. 2E and 2G; compare
ith 2C). Similar to EME B, but unlike EME 0.9SS, EME B59
nd EME B39 exhibit low levels of ectopic activity in dorsal
esodermal cells outside of the endogenous early Eve
lusters, while other embryonic regions show very little
ctopic activity (Figs. 2E and 2G; and Fig. 4A). Enhancer
ctivity of EME B59 persists in eve pericardial cells until
tage 16 (more strongly posteriorly; see stage 15 in Fig. 2F),
hile dorsal muscle founders become already negative at
id stage 12. A related fragment, termed MHE, which
hares the 39 end with EME B59 but is ;70 bp longer at the
9 end (see Fig. 3) was recently reported to also reproduce
he early mesodermal eve pattern (Halfon et al., 2000).
nlike our results with longer versions such as EME 0.9SS
Fig. 3B2), these authors did not detect any reporter gene
xpression in late myofibers with a corresponding fragment,
hich may result from the use of different transformation
ectors in the two studies.
EME B39 enhancer activity ceases prematurely at early
tage 13 in both pericardial and dorsal muscle progenitors
Fig. 2H). The identical spatial activity of EME B59 and
ME B39 at stages 11 and 12 indicates that both fragments
nclude a similar set of regulatory sequences that are
ecessary for normal early activation of mesodermal eve
xpression. Either all of these sequences are contained
ithin the ;90-bp overlap between the two fragments or
here is redundancy of individual regulatory sites within
ME B. By contrast, only EME B59 contains regulatory
equences that are sufficient for late pericardial expres-
ion, and both EME B59 and EME B39 have to cooperate to
rive expression in syncytial muscle 1 precursors at later
tages.
EME B Contains Multiple in Vitro Binding Sites for
Tinman and Wg/Dpp Effectors
The EME B fragment was tested by in vitro DNAse I
footprinting for binding sites of candidate binding factors.
The Wg-effector Pangolin (Pan, also termed Lef-1 and dTCF)
(Brunner et al., 1997; Riese et al., 1997; van de Wetering et
Copyright © 2001 by Academic Press. All rightal., 1997) protects a total of six sites, four located within
EME B59 (Pan A–Pan D) and four within EME B39 (Pan
C–Pan F; note that Pan C and Pan D are contained in the
overlap). A seventh site (Pan G) is located within EME C,
beyond the 39 end of EME B (Figs. 3, 5A, and 5B). All of these
Pan-binding sites include sequence motifs with similarities
to previously determined consensus binding sequences of
Pan and Tcf1. Pan B and Pan E, which are most strongly
protected, contain the best match to optimal or consensus
binding sites for in vitro binding of Pan/dTCF (CCTTT-
GATCT) (van de Wetering et al., 1993, 1997; Lee and
Frasch, 2000) (Fig. 3). Pan B was also identified by Halfon et
al. (2000).
The Smad4 protein Medea, which is essential to mediate
Dpp signaling (Das et al., 1998; Hudson et al., 1998;
Wisotzkey et al., 1998; Xu et al., 1998), produces a total of
ix protected sites, three within EME B59 (Med A–Med C)
nd three within EME B39 (Med D–Med F) (Figs. 3, 5C, and
D). These sites contain either the motifs AGAC, CAGA,
r GC-rich motifs, which were previously shown to bind
mad1 and Smad4 type of proteins (Kim et al., 1997;
ingling et al., 1997; Dennler et al., 1998; Xu et al., 1998;
Zawel et al., 1998). While Med B is identical with Mad5 of
Halfon et al. (2000), the remaining Smad sites within the
common sequence (positions 315 to 547; Fig. 3) differ
between the two studies. This could be explained by poten-
tial differences in the DNA binding specificities between
Mad and Medea. However, our previous data indicated that
all Medea sites can also bind Mad (although some Mad sites
do not bind Medea) (Xu et al., 1998; Lee and Frasch,
unpublished data).
Tinman produces a total of four protected sites (Figs. 5A
and 5B). Two of these, Tin A and Tin B, are in the region of
overlap between EME B59 and EME B39 and are closely
associated with the Pan C and Pan D sites, while the other
two are solely within EME B39 (Fig. 3). Only the most
strongly protected site, Tin D, contains a perfect match to
previously identified functional Tin binding sites,
TCAAGTG (Gajewski et al., 1997; Xu et al., 1998; Kremser
et al., 1999). Tin A and Tin B correspond to Tin 3 and Tin
4 of Halfon et al. (2000), but we do not detect Tin binding to
their presumed Tin 1 site and extremely weak interaction
with Tin 2 (Fig. 5A).
The zinc-finger and homeodomain encoding gene zfh-1
is required for late stage eve expression specifically in
pericardial cells (Su et al., 1999). We find that the Zfh-1
homeodomain protects a single site within EME B39,
which contains a homeodomain-consensus binding se-
quence, TAAT (Kalionis and O’Farrell, 1993), and repre-
sents the only close match to the consensus Zfh-1
homeodomain binding sequence within EME 0.9SS (For-
tini et al., 1991; see also Su et al., 1999). By contrast, the
binding motif recognized by the Zn-finger domains of
Zfh-1-type of proteins, CACCT (Postigo et al., 1999), is
not found at all within EME 0.9SS.
s of reproduction in any form reserved.
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19Integrative Inputs Controlling Mesodermal eve EnhancerBinding Sites for Tinman, Pangolin, and Smads
Are Required for Normal eve Enhancer Activity
To test the functional relevance of the binding sites
determined above, the effects of specific point mutations,
which converted them into restriction sites, as indicated in
Fig. 6, were examined in vivo. Mutations in one or two
inding sites for Tinman or Pangolin, respectively, in the
ontext of EME B, does not noticeably affect the spatiotem-
oral pattern and intensity of reporter gene expression.
hus either these sites are not utilized in vivo or they are
unctionally redundant with the additionally present un-
utated binding sites.
Previous studies have shown that the forkhead domain
ncoding gene sloppy paired (slp) is essential for mesoder-
al eve expression (Riechmann et al., 1997; Lee and Frasch,
2000), thus prompting us to examine a canonical binding
site for forkhead domain proteins that is found in EME B
(FD; Figs. 3 and 6). However, mutation of the FD sequence
does not alter EME B activity in vivo and Sloppy Paired
protein does not exhibit any binding activity toward this or
any other sequence within EME B (data not shown). This
suggests that slp activity is confined to a step further
upstream in the regulatory hierarchy and does not directly
act upon the eve promoter. It is conceivable that slp is
required to negatively regulate repressor(s) of eve within the
presumptive cardiogenic and somatic myogenic areas,
which may include bagpipe and other genes that determine
isceral mesoderm development (Riechmann et al., 1997;
ee and Frasch, 2000). Alternatively (or in addition), slp
ould be required for the segmental expression of activators
hat directly bind to the eve enhancer. Candidates for such
ctivators of eve downstream of slp could be twist (in
uscle progenitors; Baylies and Bate, 1996; Lee and Frasch,
000), L’sc, and yet unknown proteins that integrate eve
ctivation with the Notch pathway (Carmena et al., 1995,
998), or ETS proteins that may confer RTK signals to the
ve promoter (Buff et al., 1998; Carmena et al., 1998; Halfon
t al., 2000).
Because of the potential of functional redundancies of
inding sites within EME B, we continued our in vivo
nalysis of binding site mutations largely in the context of
he shorter version, EME B39, which in the wild type
ersion displays a pattern and level of activity at stages 11
nd 12 that is comparable to that of EME B (Figs. 2G and
A).
Mutation of all four Pan binding sites within EME B39
esults in a significant reduction in the levels of mesoder-
al reporter gene expression. However, in addition, pro-
ounced ectopic expression, at the same moderate levels, is
bserved along the anteroposterior axis at the dorsal margin
f the mesoderm (Figs. 4B and 4C). A similar result is
btained when five (Pan A–E) or all six Pan binding sites are
utated in the context of a variant of EME B (see Fig. 6). In
his case, the reduction in expression levels is less pro-
ounced, although ectopic activity results in almost uni-
orm expression along the dorsal margin of the mesoderm i
Copyright © 2001 by Academic Press. All rightFig. 4D). In addition, when tested in a background with
trongly reduced wg activity that generates an average of
nly one mesodermal eve cluster per embryo, this mutated
nhancer variant is still active in the dorsal mesoderm of all
runk segments (Fig. 4F; note the dramatic reduction of
ctivity with the parental EME B in the same genetic
ackground, which behaves similar to endogenous eve; Fig.
E). In a wgCX4 null mutant background, the activity of these
Pan-mutated enhancer derivatives is significantly reduced,
which is presumably attributable to the complete loss of
some Wg-dependent positively acting eve regulators such as
slp (Lee et al., 2000; data not shown).
These data suggest that in cells receiving no or low Wg
signals Pan acts as a repressor of eve, whereas in cells
receiving high Wg signals it is neutralized or converted into
an activator. These opposing activities of Pan, which may
serve to sharpen Wg responses, have also been observed in
other developmental contexts and were shown to involve
the differential binding of the corepressor Groucho and the
Wg effector Armadillo, respectively, to Pan (Cavallo et al.,
1998; Yang et al., 2000; reviewed in Bejsovec, 1999). The
observed loss of eve expression upon ectopic mesodermal
expression of a dominant negative version of Pan, which
lacks the Armadillo binding domain but retains Groucho
binding activity, is consistent with this interpretation (van
de Wetering et al., 1997; Levanon et al., 1998; Park et al.,
1998).
Mutation of the Medea binding sites E and F within EME
B39 result in a drastic loss of mesodermal cell clusters
expressing bGal, such that only a minority of transgenic
embryos retain between one and four small positive clus-
ters (Figs. 4G and 6). Additional mutation of the remaining
Medea binding site, Med D, within the same context almost
completely abolishes enhancer activity and very few em-
bryos show any bGal expression in the dorsal mesoderm
(Figs. 4H and 6). Thus, Medea binding to the eve enhancer
upon association with P-Mad appears to be a strict require-
ment for eve induction. The mild effects on mutation of
Mad-binding sites observed by Halfon et al. (2000) are likely
ascribed to the presence of at least two additional Smad
sites in their element, one of which (Med C; Fig. 5D) binds
with high affinity.
Mutation of the moderately strong Tin binding site Tin B
(which may also affect Pan binding; Fig. 3) results in a
reduction in expression levels and loss of some clusters of
bGal expression in the mesoderm (Figs. 4I and 6). Impor-
tantly, additional mutation of the strong binding site Tin D
renders the EME B39 enhancer element completely inactive
(Figs. 4J and 6). Together, these results show that, similar to
the induction of tin itself by Dpp in the entire dorsal
mesoderm that occurs slightly earlier, eve activation also
nvolves the combinatorial binding and synergistic activi-
ies of Smad and Tin proteins (Xu et al., 1998).
In contrast to the Tin sites, mutation of the Zfh-1
omeodomain binding site does not affect the early phase of
eporter gene expression during stages 10 and 11. However,
t does result in a premature decline of expression at
s of reproduction in any form reserved.
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A
a
22 Knirr and FraschFIG. 5. DNase I footprinting analysis of EME sequences using bacterially expressed Medea, Pangolin, Tinman, and Zfh-1 GST fusion
proteins. Relative protein amounts are indicated on the top, with “0” corresponding to the control lanes without bacterially expressed
proteins. The assayed EME sequences with their orientation from top to bottom are indicated below the panels. The position of weak Tin
interaction near the Tin 2 sequence of Halfon et al. (2000) is indicated in (A) by a bracket. AG: adenine/guanine sequence ladder from Sanger
ideoxy sequencing.FIG. 4. Effects of binding site mutations on the activity of eve enhancers in vivo. Embryos in panel (B), (E), and (J) are at early stage 12 and
all others are at stage 11. (A) EME B39-lacZ embryo stained for bGal protein (green) and Eve (red). (B) EME B39Pan C-F–lacZ embryo stained
as in (A). bGal expression levels are reduced and ectopic expression in dorsal mesodermal cells outside of the Eve clusters is observed. (C)
ME B39 Pan C-F–lacZ expression (bGal protein) showing reduced expression levels and ectopically expressing dorsal mesodermal cells.
ote that the single cells labeled in lateral areas of each segment (also seen in D and G) are due to a nonspecific, vector-derived effect on
xpression. In addition, all lines with this construct show expression in the caudal visceral mesoderm (cvm). (D) EME B* Pan A-E–lacZ
xpression. Strong ectopic expression all along the dorsal margin of the mesoderm is observed. (E) EME B–lacZ in a wgCX4/wgDE mutant
ackground. Significant bGal expression (green) is observed only in the single residual Eve cluster (red signals, arrow). (F) EME B* Pan
A-E–lacZ expression in wgCX4/wgDE embryo. bGal is expressed both within an Eve cluster (red, arrow) and in dorsal mesodermal cells of all
other trunk segments. (G) EME B39 Med EF–lacZ expression showing a strong reduction of enhancer activity. (H) EME B39 Med DEF–lacZ
expression. Only one small cluster is expressing bGal in the embryo shown and most transgenic embryos are completely negative. (I) EME
B39 Tin B–lacZ expression showing a reduction in the number of positive cells and expression levels. (J) EME B39 Tin BD–lacZ embryo
showing a complete lack of mesodermal bGal expression. (K) EME B39 HD/Zfh-1–lacZ embryo stained for lacZ mRNA (green) and Eve (red).t stage 11 lacZ is expressed in all mesodermal eve cells as with the parental wild type construct (see A). (L) Mid stage 12 embryo, transgene
nd staining as in K. lacZ expression in eve cells disappears prematurely.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
d23Integrative Inputs Controlling Mesodermal eve EnhancerFIG. 6. Summary of eve enhancer constructs examined in the present study. The restriction sites introduced by in vitro mutagenesis to
estroy various binding sites are denoted below each mutated construct.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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24 Knirr and Fraschmid-stage 12, that is, even earlier than with wild type EME
B39, in both pericardial and muscle progenitors (Figs. 4K, 4L,
and 6). It is possible that this effect is the result of a
disruption of Zfh-1 binding, although we cannot exclude
the possibility that a different (perhaps homeodomain)
binding factor interacts with this site in vivo. The observa-
tion that the overlapping EME B59 fragment is active in eve
pericardial cells until late stages, and yet lacks a bona fide
Zfh-1 binding site, would suggest that zfh-1 plays a largely
indirect role in the maintenance of eve expression. In light
of its proposed activity as a transcriptional repressor, it is
conceivable that it negatively regulates a repressor of eve
(Postigo et al., 1999). Likewise, DNase I footprinting did not
detect any Kru¨ppel binding site within EME B, thus sug-
gesting that the requirement for Kru¨ppel in the mainte-
nance of eve expression in muscle 1 precursors is also
indirect. Binding sites for Ladybird (Lb), which has been
implicated in repression of eve (Jagla et al., 1997), were also
not detected (data not shown).
Sequential and Integrative Mechanisms in eve
Regulation
The expression of eve identifies a small subset of pericar-
dial and somatic muscle progenitors and its onset coincides
with the processes that determine their developmental
fates. Although eve itself cannot be sufficient to specify the
distinct identities of these cells, it may fulfill such a
function in specific combinations with additional regula-
tors, such as Kru¨ppel (in muscle 1 progenitors) (Ruiz-Gomez
t al., 1997) and runt (in muscle 10 progenitors) (Halfon et
al., 2000). Therefore, eve activation can serve as a paradigm
for studying the genetic and molecular processes that de-
termine the identities of individual muscle and heart pro-
genitors.
Previous work has provided insight into the regulatory
cascades and some of their components that are critical for
eve expression (reviewed in Frasch, 1999; Frasch and
Nguyen, 1999). These studies showed that the combined
activities of tin and slp, which themselves are induced in
the mesoderm by Dpp and Wg, respectively, are required
but not sufficient for eve activation. Further, ectopic ex-
pression of slp and wg in combination, but not of either
component alone, resulted in uniform eve expression along
the dorsal margin of the mesoderm (Lee and Frasch, 2000).
These and other data indicated that wg and possibly also
dpp are required during multiple steps in the regulatory
cascade of eve induction. The results of our present study
and a related analysis (Halfon et al., 2000) confirm that
there is a renewed requirement for Wg and Dpp signaling at
the level of eve activation. More generally, this means that
these two signaling molecules first induce the spatially
restricted and overlapping expression of prepatterning genes
in the mesoderm and subsequently act again, this time in
conjunction with the products of prepatterning genes, to
induce genes that determine the identities of heart and
muscle progenitors. During this downstream step, the re-
Copyright © 2001 by Academic Press. All rightstricted areas of overlap between prepatterning gene expres-
sion patterns determine the domains in which cells are
competent to respond to signals.
The molecular data presented herein and by Halfon et al.
(2000) show that the integration of the regulators of eve
involves the direct interaction of Dpp and Wg effectors as
well as Tin (but not Slp) with a mesodermal eve enhancer.
Tin and Dpp-activated Smads appear to synergize to allow
eve induction, analogous to the situation that was described
for the broad induction of tin in the dorsal mesoderm (Xu et
al., 1998). However, this raises the question of why, unlike
the case of tin, the combined activities of Smads and Tin are
unable to induce eve in the whole dorsal mesoderm. A
likely explanation is that negative regulators bind to the eve
enhancer and abrogate the synergistic activities of Smads
and Tin. Based on our analysis these negative regulators
include Pangolin (Lef1), and the ETS protein Yan was
identified by Halfon et al. (2000) as a negative factor in this
process. In our current view, the role of Wg and RTK
signaling would be to neutralize these negative regulators
and convert them into positive ones, which would then
enable Smads and Tin to activate eve exclusively in the
cells that receive these additional signals.
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